CG Oncology, Inc. (CGON) Operating cash flow 2023–2025
CG Oncology, Inc. (CGON) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$132.3MFY2025 · since FY2023: -$45.7M → -$132.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.3M | -68.1% |
| FY2024 | -$78.7M | -72.3% |
| FY2023 | -$45.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGON financial trends
CGON RevenueCGON Net incomeCGON Net marginCGON Gross profitCGON Gross marginCGON Operating incomeCGON Operating marginCGON Free cash flowCGON Capital expendituresCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Total liabilitiesCGON Shareholders’ equityCGON overview →